Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy

The prevalence of pulmonary hypertension (PH) complicating interstitial lung diseases (ILDs) is 3.5–15% at an early stage, and up to 90% in ILD patients listed for lung transplantation. In addition, other types of PH may occur in patients with ILDs due to concomitant conditions. Therefore, any signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kacprzak, Aneta, Tomkowski, Witold, Szturmowicz, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378268/
https://www.ncbi.nlm.nih.gov/pubmed/37510098
http://dx.doi.org/10.3390/diagnostics13142354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378268/
https://www.ncbi.nlm.nih.gov/pubmed/37510098
http://dx.doi.org/10.3390/diagnostics13142354

Ejemplares similares